| Dr Heike Ingrid Ballmaier, PSYD BCBA | |
|
1000 S Fremont Ave, Alhambra, CA 91803-8800 | |
| (626) 299-4700 | |
| Not Available |
| Full Name | Dr Heike Ingrid Ballmaier |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 1000 S Fremont Ave, Alhambra, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134302581 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY16085 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heike Ingrid Ballmaier, PSYD BCBA 1107 Fair Oaks Ave # 831, South Pasadena, CA 91030-3311 Ph: (626) 298-3588 | Dr Heike Ingrid Ballmaier, PSYD BCBA 1000 S Fremont Ave, Alhambra, CA 91803-8800 Ph: (626) 299-4700 |
News Archive
A new study highlights inconsistencies in black box warnings - medication-related safety warnings on a drug's label - and argues for a more transparent and systematic approach to ensure these warnings are consistent across all drugs within a same category, and any additions to warnings, on the back of a drug withdrawal for example, are done within a reasonable and uniform time period.
Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.
Hopeful that some of the same antiretroviral (ARV) drugs used to treat HIV infection can also prevent it, researchers from the Microbicide Trials Network have enrolled the first participants into a new, large-scale clinical trial testing two approaches of the strategy in women.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.
› Verified 3 days ago
Dr. Mark David Hassan, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1961 W Huntington Dr Ste 202, Alhambra, CA 91801 Phone: 626-458-5444 Fax: 626-458-0679 | |
Michael Wood, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 502 N Electric Ave Apt D, Alhambra, CA 91801 Phone: 510-290-0586 | |
Dr. Alyssa Cohen, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Bldg A-9, Alhambra, CA 91803 Phone: 626-299-3534 | |
Gali Helena Weissberger, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Unit 22, Alhambra, CA 91803 Phone: 818-825-5852 | |
Shakiba Amini Mobaraki, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 301 N Monterey St, Alhambra, CA 91801 Phone: 626-458-4561 | |
Chrystal Chan, LMFT, PPS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 118 E Huntington Dr Ste E, Alhambra, CA 91801 Phone: 626-888-2203 |